BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16310235)

  • 1. Evaluation of the antibody response to Anopheles salivary antigens as a potential marker of risk of malaria.
    Remoue F; Cisse B; Ba F; Sokhna C; Herve JP; Boulanger D; Simondon F
    Trans R Soc Trop Med Hyg; 2006 Apr; 100(4):363-70. PubMed ID: 16310235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of antibody response to Plasmodium falciparum in children according to exposure of Anopheles gambiae s.l or Anopheles funestus vectors.
    Sarr JB; Remoue F; Samb B; Dia I; Guindo S; Sow C; Maiga S; Tine S; Thiam C; Schacht AM; Simondon F; Konate L; Riveau G
    Malar J; 2007 Sep; 6():117. PubMed ID: 17764568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An insight into immunogenic salivary proteins of Anopheles gambiae in African children.
    Cornelie S; Remoue F; Doucoure S; Ndiaye T; Sauvage FX; Boulanger D; Simondon F
    Malar J; 2007 Jun; 6():75. PubMed ID: 17550586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do antibody responses to malaria vaccine candidates influenced by the level of malaria transmission protect from malaria?
    Nebie I; Tiono AB; Diallo DA; Samandoulougou S; Diarra A; Konate AT; Cuzin-Ouattara N; Theisen M; Corradin G; Cousens S; Ouattara AS; Ilboudo-Sanogo E; Sirima BS
    Trop Med Int Health; 2008 Feb; 13(2):229-37. PubMed ID: 18304269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bionomics of malaria vectors and relationship with malaria transmission and epidemiology in three physiographic zones in the Senegal River Basin.
    Dia I; Konate L; Samb B; Sarr JB; Diop A; Rogerie F; Faye M; Riveau G; Remoue F; Diallo M; Fontenille D
    Acta Trop; 2008 Feb; 105(2):145-53. PubMed ID: 18068685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Specific antibodies to Plasmodium falciparum antigens in immune patients: IV--Cross-sectional analysis of anti-P. falciparum Ab responses in a mesoendemic zone of transmission in Sine-Saloum region].
    Sidibé S; Diouf B; Tall A; Spiegel A; Trape JF; Garraud O; Dièye A; Perraut P
    Dakar Med; 2000; 45(2):117-21. PubMed ID: 15779164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium falciparum transmission blocking immunity in three areas with perennial or seasonal endemicity and different levels of transmission.
    Boudin C; Diop A; Gaye A; Gadiaga L; Gouagna C; Safeukui I; Bonnet S
    Am J Trop Med Hyg; 2005 Dec; 73(6):1090-5. PubMed ID: 16354818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of varying exposure to malaria transmission on development of antimalarial antibody responses in preschool children. XVI. Asembo Bay Cohort Project.
    Singer LM; Mirel LB; ter Kuile FO; Branch OH; Vulule JM; Kolczak MS; Hawley WA; Kariuki SK; Kaslow DC; Lanar DE; Lal AA
    J Infect Dis; 2003 Jun; 187(11):1756-64. PubMed ID: 12751033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of infection by Plasmodium falciparum on the melanization immune response of Anopheles gambiae.
    Lambrechts L; Morlais I; Awono-Ambene PH; Cohuet A; Simard F; Jacques JC; Bourgouin C; Koella JC
    Am J Trop Med Hyg; 2007 Mar; 76(3):475-80. PubMed ID: 17360870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of urbanisation on bionomics and distribution of malaria vectors in Lagos, southwestern Nigeria.
    Oyewole IO; Awolola TS
    J Vector Borne Dis; 2006 Dec; 43(4):173-8. PubMed ID: 17175702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium falciparum infection during dry season: IgG responses to Anopheles gambiae salivary gSG6-P1 peptide as sensitive biomarker for malaria risk in Northern Senegal.
    Sagna AB; Gaayeb L; Sarr JB; Senghor S; Poinsignon A; Boutouaba-Combe S; Schacht AM; Hermann E; Faye N; Remoue F; Riveau G
    Malar J; 2013 Aug; 12():301. PubMed ID: 23988032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderate transmission but high prevalence of malaria in Madagascar.
    Robert V; Le Goff G; Andrianaivolambo L; Randimby FM; Domarle O; Randrianarivelojosia M; Raharimanga V; Raveloson A; Ravaonjanahary C; Ariey F
    Int J Parasitol; 2006 Oct; 36(12):1273-81. PubMed ID: 16842796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential acquisition of human antibody responses to Plasmodium falciparum according to intensity of exposure to Anopheles bites.
    Sarr JB; Samb B; Sagna AB; Fortin S; Doucoure S; Sow C; Senghor S; Gaayeb L; Guindo S; Schacht AM; Rogerie F; Hermann E; Dia I; Konate L; Riveau G; Remoue F
    Trans R Soc Trop Med Hyg; 2012 Aug; 106(8):460-7. PubMed ID: 22721883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological signatures of declining exposure following intensification of integrated malaria control in two rural Senegalese communities.
    Perraut R; Varela ML; Loucoubar C; Niass O; Sidibé A; Tall A; Trape JF; Wotodjo AN; Mbengue B; Sokhna C; Vigan-Womas I; Touré A; Richard V; Mercereau-Puijalon O
    PLoS One; 2017; 12(6):e0179146. PubMed ID: 28609450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An. gambiae gSG6-P1 evaluation as a proxy for human-vector contact in the Americas: a pilot study.
    Londono-Renteria B; Drame PM; Weitzel T; Rosas R; Gripping C; Cardenas JC; Alvares M; Wesson DM; Poinsignon A; Remoue F; Colpitts TM
    Parasit Vectors; 2015 Oct; 8():533. PubMed ID: 26464073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human IgG response to a salivary peptide, gSG6-P1, as a new immuno-epidemiological tool for evaluating low-level exposure to Anopheles bites.
    Poinsignon A; Cornelie S; Ba F; Boulanger D; Sow C; Rossignol M; Sokhna C; Cisse B; Simondon F; Remoue F
    Malar J; 2009 Aug; 8():198. PubMed ID: 19674487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High gametocyte complexity and mosquito infectivity of Plasmodium falciparum in the Gambia.
    Nwakanma D; Kheir A; Sowa M; Dunyo S; Jawara M; Pinder M; Milligan P; Walliker D; Babiker HA
    Int J Parasitol; 2008 Feb; 38(2):219-27. PubMed ID: 17709108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in exposure to Anopheles gambiae salivary gland peptide (gSG6-P1) across different malaria transmission settings in the western Kenya highlands.
    Badu K; Siangla J; Larbi J; Lawson BW; Afrane Y; Ong'echa J; Remoue F; Zhou G; Githeko AK; Yan G
    Malar J; 2012 Sep; 11():318. PubMed ID: 22963464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses to several malaria pre-erythrocytic antigens as a marker of malaria exposure among travelers.
    Orlandi-Pradines E; Penhoat K; Durand C; Pons C; Bay C; Pradines B; Fusai T; Josse R; Dubrous P; Meynard JB; Durand JP; Migliani R; Boutin JP; Druilhe P; Rogier C
    Am J Trop Med Hyg; 2006 Jun; 74(6):979-85. PubMed ID: 16760507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of Plasmodium falciparum gametocytes: weapons of mass dispersion.
    Drakeley C; Sutherland C; Bousema JT; Sauerwein RW; Targett GA
    Trends Parasitol; 2006 Sep; 22(9):424-30. PubMed ID: 16846756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.